CEROX1

Across TCGA pan-cancer cohorts, CEROX1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CEROX1 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher CEROX1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CEROX1 expression acts as an unfavorable survival marker, although some lineages such as LGG and KICH show a favorable association.

LGG, KICH, and HNSC are the cancer types where CEROX1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.541	0.353	<.001	51	view →
KICH	DFS	Median	III,IV	1.000	0.428	.004	50	view →
HNSC	OS	Tertile	III,IV	0.497	0.220	.004	32	view →
PRAD	DFS	Median	All	0.832	0.931	<.001	18	view →
BRCA	DFS	Quartile	IV	0.355	0.841	.005	16	view →
ACC	DFS	Quartile	II,III,IV	0.145	0.570	.014	16	view →
UCS	OS	Tertile	IV	0.302	1.000	.036	14	view →
READ	OS	Median	IV	1.000	0.587	.013	14	view →
CESC	OS	Quartile	All	0.840	0.686	.012	14	view →
GBM	DFS	Median	All	0.382	0.187	.004	12	view →
THYM	DFS	Tertile	II,III,IV	0.589	1.000	.015	9	view →
LIHC	OS	Tertile	All	0.567	0.316	.021	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CEROX1–LGG (OS)

Open the LGG breakdown →